AstraZeneca moved to strengthen its core oncology business on Tuesday with three deals designed to expand the British drugmaker's reach in treating tumors.
Pharmacyclics
Breaking News
Subscribe to VCpost newsletter
Most Popular
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- IBM Set to Acquire HashiCorp in Possible Mega-Deal, Stock Skyrockets 24% to $6.1 Billion Valuation
- Samsung to Implement Six-Day Work Week for Executives Slammed by Critics 'Not Effective'
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- TikTok Ban in US Almost Inevitable After Senate Approves Bill Forcing Parent Company to Divest Owvnership or Face Prohibition
- Philippines Wants US, Japan to Fund Freight Railway Project After It Drops Funding Talks With China
